Cigna Group $CI Shares Bought by Entropy Technologies LP

Entropy Technologies LP grew its holdings in Cigna Group (NYSE:CI) by 57.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 15,166 shares of the health services provider’s stock after acquiring an additional 5,536 shares during the period. Entropy Technologies LP’s holdings in Cigna Group were worth $4,372,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Norges Bank purchased a new position in Cigna Group in the second quarter valued at about $1,110,426,000. Capital Research Global Investors boosted its position in shares of Cigna Group by 140.2% in the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after buying an additional 1,855,897 shares during the period. Arrowstreet Capital Limited Partnership grew its stake in shares of Cigna Group by 24.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock valued at $829,339,000 after buying an additional 492,045 shares in the last quarter. Balyasny Asset Management L.P. grew its stake in shares of Cigna Group by 1,057.2% in the second quarter. Balyasny Asset Management L.P. now owns 404,753 shares of the health services provider’s stock valued at $133,803,000 after buying an additional 369,775 shares in the last quarter. Finally, Man Group plc raised its holdings in shares of Cigna Group by 215.5% during the 2nd quarter. Man Group plc now owns 532,183 shares of the health services provider’s stock valued at $175,929,000 after buying an additional 363,510 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.70% of the stock is currently owned by insiders.

Cigna Group Stock Performance

Shares of CI opened at $266.41 on Friday. The firm has a market cap of $70.21 billion, a price-to-earnings ratio of 12.01, a PEG ratio of 0.90 and a beta of 0.27. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. The business’s 50 day moving average is $279.83 and its two-hundred day moving average is $283.17. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. The business had revenue of $72.50 billion during the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter last year, the company earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be issued a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, March 5th. This represents a $6.24 annualized dividend and a yield of 2.3%. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio (DPR) is 28.13%.

Wall Street Analysts Forecast Growth

CI has been the subject of a number of analyst reports. Truist Financial upped their price target on Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a report on Tuesday, February 17th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Cigna Group from $301.00 to $304.00 and gave the company a “buy” rating in a research note on Tuesday, February 10th. Guggenheim reissued a “buy” rating and set a $318.00 target price on shares of Cigna Group in a research report on Monday, February 2nd. Leerink Partners raised their price target on shares of Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a report on Friday, February 6th. Finally, Barclays dropped their price target on shares of Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a research note on Friday, February 6th. One research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $333.11.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.